| Noninvasive evaluation of airway inflammation in asthmatic patients who smoke: implications for application in clinical practice. | |
| | |
MedLine Citation:
|
PMID: 18814444 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Despite the limited pathological data in asthmatic patients who smoke, it is thought that cigarette smoking may modify airway inflammation. OBJECTIVES: To summarize the major clinical studies that have used samples obtained by noninvasive techniques, such as blood, urine, exhaled breath condensate (EBC), fractional exhaled nitric oxide (FeNO), and induced sputum, for the evaluation of airway inflammation and the response to treatment in asthmatic patients who smoke and to evaluate which biomarkers have been adequately validated to be used in routine clinical practice. DATA SOURCES: In this review, we collected the available literature that addressed this topic. We searched the MEDLINE database using a combination of the following keywords: smoking or asthma or inflammation or mechanisms or exhaled nitric oxide or induced sputum or EBC. STUDY SELECTION: We selected the articles that most adequately addressed this topic for inclusion in this review. RESULTS: Smoking significantly influences FeNO and negatively affects its concentration, although FeNO can distinguish steroid-naive asthmatic smokers from nonasthmatic smokers. Sputum neutrophilia is the predominant finding in induced sputum in asthmatic patients who smoke but inflammatory mediators derived either from neutrophils or from a T(H)1 response can also be measured in the supernatants. EBC gives the opportunity to evaluate neutrophil-derived cytokines, airway acidification, and plausible protective mechanisms in smoking asthma. CONCLUSIONS: Despite the encouraging updated results, the introduction of noninvasive techniques in daily clinical practice requires the reworking of some methodologic pitfalls and the identification of a reliable biomarker that is reproducible, possesses normal values, and provides information for the underlying inflammatory process and the response to treatment. |
| | |
Authors:
|
Vasiliki Bessa; Eleni Tseliou; Petros Bakakos; Stelios Loukides |
Related Documents
:
|
3197994 - Smoking and sugar intake are separate but interactive risk factors in crohn's disease. 7992674 - Is sham smoking an adequate control condition for the motoric component of smoking? 20578624 - Association of passive smoking with respiratory symptoms and clinical correlates, among... 21793874 - "let me count the ways:" fostering reasons for living among low-income, suicidal, afric... 19515594 - Prevalence and antibiotic susceptibility of mycoplasma hominis and ureaplasma urealytic... 16538554 - A referent bone mineral density database for chinese american women. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology Volume: 101 ISSN: 1081-1206 ISO Abbreviation: Ann. Allergy Asthma Immunol. Publication Date: 2008 Sep |
Date Detail:
|
Created Date: 2008-09-25 Completed Date: 2008-10-31 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9503580 Medline TA: Ann Allergy Asthma Immunol Country: United States |
Other Details:
|
Languages: eng Pagination: 226-32; quiz 232-4, 278 Citation Subset: IM |
Affiliation:
|
Second Respiratory Medicine Department, Medical School, University of Athens, Athens, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Asthma / diagnosis*, metabolism Biological Markers / blood, metabolism, urine Breath Tests / methods Bronchitis / diagnosis*, metabolism Humans Lung / metabolism, pathology Smoking* Sputum / cytology, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Central venous pressure--evaluation, interpretation, monitoring, clinical implications.
Next Document: The burden of rhinitis in a managed care organization.